Allogene Therapeutics, Inc.
US ˙ NasdaqGS ˙ US0197701065

SecurityALLO / Allogene Therapeutics, Inc.
InstitutionSimplex Trading, Llc
Latest Disclosed Ownership53,282 shares
Latest Disclosed Value $ 130,008
Simplex Trading, Llc ownership in ALLO / Allogene Therapeutics, Inc.

On May 14, 2026 - Simplex Trading, Llc filed a 13F-HR form disclosing ownership of 53,282 shares of Allogene Therapeutics, Inc. (US:ALLO) valued at $130,008 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 6,133 shares of Allogene Therapeutics, Inc.. This represents a change in shares of 768.78% during the quarter. The current value of the position is $106,564 USD.

Simplex Trading, Llc has a history of taking positions in derivatives of the underlying security (ALLO) in the form of stock options. The firm currently holds call options representing 27,000 of underlying shares valued at $65,880 USD and put options representing 27,800 of underlying shares valued at $67,832 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ALLO / Allogene Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 53,282 47,149 768.78 130 1,525.00 0.0000
2026-02-11 2025-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 6,133 1,952 46.69 8 0.0000
2025-11-12 2025-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 4,181 -12,848 -75.45 0 0.0000
2025-08-05 2025-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 17,029 -642 -3.63 0 0.0000
2025-05-12 2025-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 17,671 -50,640 -74.13 0 0.0000
2025-02-11 2024-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 68,311 41,181 151.79 0 0.0001
2024-11-08 2024-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 27,130 27,130 0 0.0000
2024-04-25 2024-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -20,210 -100.00 0 0.0000
2024-02-02 2023-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 20,210 20,210 0 0.0000
2023-11-01 2023-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 0 -7,821 -100.00 0 0.0000
2023-08-04 2023-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 7,821 -105,528 -93.10 0 0.0000
2023-04-27 2023-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 113,349 113,349 1 0.0005
2023-02-02 2022-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -2,050 -100.00 0 -100.00
2022-11-04 2022-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 2,050 2,050 22 0.0000
2022-05-02 2022-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 0 -6,605 -100.00 0 -100.00
2022-02-23 2021-12-31 13F/A-1 ALLOGENE THERAPEUTICS COM 019770106 6,605 2,455 59.16 98 -10.91 0.0001
2022-02-04 2021-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 4,150 0 110 0.0000
2021-10-28 2021-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 4,150 -200 -4.60 110 -2.65 0.0001
2021-08-12 2021-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 4,350 -16,332 -78.97 113 -84.52 0.0001
2021-04-26 2021-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 20,682 19,959 2,760.58 730 3,955.56 0.0013
2021-02-02 2020-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 723 723 -96.50 18 -97.53 0.0000
2020-07-13 2020-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 0 -2,109 -100.00 0 -100.00
2020-04-29 2020-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 2,109 2,109 40 0.0001
2019-10-15 2019-09-30 13F ALLOGENE THERAPEUTICS COM 019770106 0 -157 -100.00 0 -100.00
2019-07-26 2019-06-30 13F ALLOGENE THERAPEUTICS COM 019770106 157 -6,148 -97.51 4 -97.80 0.0000
2019-04-18 2019-03-31 13F ALLOGENE THERAPEUTICS COM 019770106 6,305 6,188 5,288.89 182 5,966.67 0.0005
2019-01-16 2018-12-31 13F ALLOGENE THERAPEUTICS COM 019770106 117 117 3 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ALLOGENE THERAPEUTICS CALL Call 27,000 770.97 66 1,525.00 n/a n/a n/a
2026-02-11 2025-12-31 13F ALLOGENE THERAPEUTICS CALL Call 3,100 -80.98 4 n/a n/a n/a
2025-11-12 2025-09-30 13F ALLOGENE THERAPEUTICS CALL Call 16,300 71.58 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ALLOGENE THERAPEUTICS CALL Call 9,500 -3.06 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ALLOGENE THERAPEUTICS CALL Call 9,800 180.00 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ALLOGENE THERAPEUTICS CALL Call 3,500 -93.72 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ALLOGENE THERAPEUTICS CALL Call 55,700 -18.92 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ALLOGENE THERAPEUTICS CALL Call 68,700 -2.83 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ALLOGENE THERAPEUTICS CALL Call 70,700 5,338.46 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ALLOGENE THERAPEUTICS CALL Call 1,300 -74.00 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ALLOGENE THERAPEUTICS CALL Call 5,000 42.86 0 n/a n/a n/a
2023-08-04 2023-06-30 13F ALLOGENE THERAPEUTICS CALL Call 3,500 -78.26 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ALLOGENE THERAPEUTICS CALL Call 16,100 -59.55 0 n/a n/a n/a
2023-02-02 2022-12-31 13F ALLOGENE THERAPEUTICS CALL Call 39,800 167.11 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ALLOGENE THERAPEUTICS CALL Call 14,900 -15.82 160 -20.40 n/a n/a n/a
2022-08-03 2022-06-30 13F ALLOGENE THERAPEUTICS CALL Call 17,700 90.32 201 139.29 n/a n/a n/a
2022-05-02 2022-03-31 13F ALLOGENE THERAPEUTICS CALL Call 9,300 30.99 84 -20.00 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ALLOGENE THERAPEUTICS CALL Call 7,100 343.75 105 150.00 n/a n/a n/a
2022-02-04 2021-12-31 13F ALLOGENE THERAPEUTICS CALL Call 1,600 42 n/a n/a n/a
2021-10-28 2021-09-30 13F ALLOGENE THERAPEUTICS CALL Call 1,600 0.00 42 2.44 n/a n/a n/a
2021-08-12 2021-06-30 13F ALLOGENE THERAPEUTICS CALL Call 1,600 912.66 41 -92.64 n/a n/a n/a
2021-04-26 2021-03-31 13F ALLOGENE THERAPEUTICS CALL Call 158 -3.66 557 34.87 n/a n/a n/a
2021-02-02 2020-12-31 13F ALLOGENE THERAPEUTICS CALL Call 164 1,722.22 413 1,151.52 n/a n/a n/a
2020-10-14 2020-09-30 13F ALLOGENE THERAPEUTICS CALL Call 9 -85.48 33 -87.55 n/a n/a n/a
2020-07-13 2020-06-30 13F ALLOGENE THERAPEUTICS CALL Call 62 376.92 265 960.00 n/a n/a n/a
2020-04-29 2020-03-31 13F ALLOGENE THERAPEUTICS CALL Call 13 -95.58 25 -96.72 n/a n/a n/a
2020-02-05 2019-12-31 13F ALLOGENE THERAPEUTICS CALL Call 294 314.08 763 295.34 n/a n/a n/a
2019-10-15 2019-09-30 13F ALLOGENE THERAPEUTICS CALL Call 71 86.84 193 89.22 n/a n/a n/a
2019-07-26 2019-06-30 13F ALLOGENE THERAPEUTICS CALL Call 38 -5.00 102 -11.30 n/a n/a n/a
2019-04-18 2019-03-31 13F ALLOGENE THERAPEUTICS CALL Call 40 900.00 115 1,050.00 n/a n/a n/a
2019-01-16 2018-12-31 13F ALLOGENE THERAPEUTICS CALL Call 4 10 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-14 2026-03-31 13F ALLOGENE THERAPEUTICS PUT Put 27,800 892.86 68 2,133.33 n/a n/a n/a
2026-02-11 2025-12-31 13F ALLOGENE THERAPEUTICS PUT Put 2,800 -9.68 4 n/a n/a n/a
2025-11-12 2025-09-30 13F ALLOGENE THERAPEUTICS PUT Put 3,100 -84.73 0 n/a n/a n/a
2025-08-05 2025-06-30 13F ALLOGENE THERAPEUTICS PUT Put 20,300 -9.78 0 n/a n/a n/a
2025-05-12 2025-03-31 13F ALLOGENE THERAPEUTICS PUT Put 22,500 -24.50 0 n/a n/a n/a
2025-02-11 2024-12-31 13F ALLOGENE THERAPEUTICS PUT Put 29,800 2.76 0 n/a n/a n/a
2024-11-08 2024-09-30 13F ALLOGENE THERAPEUTICS PUT Put 29,000 262.50 0 n/a n/a n/a
2024-07-25 2024-06-30 13F ALLOGENE THERAPEUTICS PUT Put 8,000 627.27 0 n/a n/a n/a
2024-04-25 2024-03-31 13F ALLOGENE THERAPEUTICS PUT Put 1,100 120.00 0 n/a n/a n/a
2024-02-02 2023-12-31 13F ALLOGENE THERAPEUTICS PUT Put 500 0 n/a n/a n/a
2023-11-01 2023-09-30 13F ALLOGENE THERAPEUTICS PUT Put 0 -100.00 0 n/a n/a n/a
2023-08-04 2023-06-30 13F ALLOGENE THERAPEUTICS PUT Put 200 -99.85 0 n/a n/a n/a
2023-04-27 2023-03-31 13F ALLOGENE THERAPEUTICS PUT Put 134,900 19,171.43 1 n/a n/a n/a
2023-02-02 2022-12-31 13F ALLOGENE THERAPEUTICS PUT Put 700 -94.17 0 -100.00 n/a n/a n/a
2022-11-04 2022-09-30 13F ALLOGENE THERAPEUTICS PUT Put 12,000 2,900.00 129 3,125.00 n/a n/a n/a
2022-08-03 2022-06-30 13F ALLOGENE THERAPEUTICS PUT Put 400 -71.43 4 -66.67 n/a n/a n/a
2022-05-02 2022-03-31 13F ALLOGENE THERAPEUTICS PUT Put 1,400 -30.00 12 -58.62 n/a n/a n/a
2022-02-23 2021-12-31 13F/A ALLOGENE THERAPEUTICS PUT Put 2,000 -75.61 29 -86.64 n/a n/a n/a
2022-02-04 2021-12-31 13F ALLOGENE THERAPEUTICS PUT Put 8,200 217 n/a n/a n/a
2021-10-28 2021-09-30 13F ALLOGENE THERAPEUTICS PUT Put 8,200 0.00 217 1.88 n/a n/a n/a
2021-08-12 2021-06-30 13F ALLOGENE THERAPEUTICS PUT Put 8,200 102,400.00 213 660.71 n/a n/a n/a
2021-04-26 2021-03-31 13F ALLOGENE THERAPEUTICS PUT Put 8 14.29 28 64.71 n/a n/a n/a
2021-02-02 2020-12-31 13F ALLOGENE THERAPEUTICS PUT Put 7 600.00 17 466.67 n/a n/a n/a
2020-10-14 2020-09-30 13F ALLOGENE THERAPEUTICS PUT Put 1 -98.72 3 -99.10 n/a n/a n/a
2020-07-13 2020-06-30 13F ALLOGENE THERAPEUTICS PUT Put 78 168.97 333 494.64 n/a n/a n/a
2020-04-29 2020-03-31 13F ALLOGENE THERAPEUTICS PUT Put 29 -86.26 56 -89.78 n/a n/a n/a
2020-02-05 2019-12-31 13F ALLOGENE THERAPEUTICS PUT Put 211 539.39 548 515.73 n/a n/a n/a
2019-10-15 2019-09-30 13F ALLOGENE THERAPEUTICS PUT Put 33 65.00 89 67.92 n/a n/a n/a
2019-07-26 2019-06-30 13F ALLOGENE THERAPEUTICS PUT Put 20 -92.98 53 -93.56 n/a n/a n/a
2019-04-18 2019-03-31 13F ALLOGENE THERAPEUTICS PUT Put 285 4,650.00 823 5,043.75 n/a n/a n/a
2019-01-16 2018-12-31 13F ALLOGENE THERAPEUTICS PUT Put 6 16 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.